Get started
Author

Kathrin Philipp‐Abbrederis

Observed names: K. Philipp-Abbrederis, Kathrin Philipp-Abbrederis, Philipp-Abbrederis, Kathrin
OpenAlex ID: A5073129682
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
2015 · Kathrin Philipp‐Abbrederis, Ken Herrmann, et al. · EMBO Molecular Medicine · 222
PDF
Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging
2015 · Hans Jürgen Wester, Ulrich Keller, et al. · Theranostics · 198
PDF
First Experience with Chemokine Receptor CXCR4–Targeted PET Imaging of Patients with Solid Cancers
2016 · Tibor Vag, Carlos Gerngross, et al. · Journal of Nuclear Medicine · 147
PDF
Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
2022 · Margaret A. Tempero, Uwe Pelzer, et al. · Journal of Clinical Oncology · 146
PDF
Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia
2016 · P. Herhaus, S. Habringer, et al. · Haematologica · 67
PDF
The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study
2020 · Jakob Michael Riedl, Florian Posch, et al. · Therapeutic Advances in Medical Oncology · 56
Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study
2020 · Gerald W. Prager, Leopold Oehler, et al. · European Journal of Cancer · 29
Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.
2013 · Zhoulei Li, Ken Herrmann, et al. · PubMed · 12
Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
2022 · Verena Petzer, Normann Steiner, et al. · HemaSphere · 10
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18–65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network
2026 · Martin Dreyling, Martin Dreyling, et al. · The Lancet · 9
[68Ga]Pentixafor: A Novel PET Tracer for Imaging CXCR4 Status in Patients with Multiple Myeloma
2014 · Kathrin Philipp-Abbrederis, Ken Herrmann, et al. · Blood · 5
The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study
2019 · J. Riedl, F. Posch, et al. · Annals of Oncology · 4
PDF
What’s new in small cell lung cancer – extensive disease? An overview on advances of systemic treatment in 2016
2017 · Andreas Seeber, Christoph Leitner, et al. · Future Oncology · 4
Austrian Real-world Experience With Standard of Care Brexucabtagene Autoleucel in Patients With Relapsed or Refractory Mantle-Cell Lymphoma
2026 · Stefan Koeck, Natalia Rotter, et al. · Transplantation and Cellular Therapy · 1
Austrian real world data in elderly and younger metastatic pancreatic cancer patients: Interim results of a multicenter non-interventional study with nab-paclitaxel/gemcitabine
2018 · W. Eisterer, A. Gerger, et al. · Annals of Oncology
Real life registry data of primary localisation of a well-defined colon cancer population of western Austria (Salzburg, Tyrol and Vorarlberg), eastern Switzerland (St. Gallen and Graubünden) and Liechtenstein
2017 · B.L. Hartmann, W. Oberaigner, et al. · Annals of Oncology
Identification of CXCR4 Expression By Targeted PET/MR Imaging in Patients with Acute Myeloid Leukemia (AML)
2015 · Peter Herhaus, Stefan Habringer, et al. · Blood
Changes in the tumor glucose-uptake measured by 18F-FDG PET with two weeks of single-agent cetuximab in localized squamous cell carcinoma of the esophagus.
2013 · Kathrin Philipp-Abbrederis, Ken Herrmann, et al. · Journal of Clinical Oncology
Works count: 20
Citation count: 910
H-index: 9
I10-index: 9
Year
Topic
Type